BofA lowered the firm’s price target on Salesforce (CRM) to $325 from $350 and keeps a Buy rating on the shares. Recent talks with partners suggest that deal activity leaned more “in line” with expectations during Q2, says the analyst, who expects Q2 revenue and cRPO to be largely in line with its estimates for $10.1B and $19.2B, respectively. Inline results are “not likely to be a catalyst for the stock,” the analyst added in the firm’s preview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRM:
- VOO ETF News, 8/26/2025
- Salesforce Buy Rating Backed by Promising H2 Outlook and AI Advancements
- Top Investor Endorses Bullish Mode for Salesforce Stock (CRM)
- Option traders moderately bearish in Salesforce with shares down 0.19%
- Top Analyst Stays Neutral on Salesforce (NYSE:CRM) amid AI Momentum and Slowing Growth